One of the issues that the medical world is working on is making pregnancy possible at older ages.

Clinical trials and research conducted in the United States have revealed that inactive cells in the ovaries have the potential to turn into egg cells when sufficiently stimulated by platelets. This discovery will change all the scientific facts we know so far about female reproductive physiology.

Platelets contain large amounts of growth factors. This feature plays an important role for the activation of quiescent stem cells in the ovaries. Injecting plaques obtained from the person's own blood and enriched in a laboratory environment directly into the ovaries will potentially activate the stem cells in the ovaries and trigger the production of new eggs.

What we have observed in the cases we have performed so far is that even the menopause of women does not constitute an obstacle for this procedure. In short, it is possible to ensure egg production even after menopause.

Since platelet injections are obtained from the person's own blood sample, they do not cause any allergic reactions, are not rejected by the body, and have almost no side effects.

Platelet injection is a fairly new practice. This treatment, which we are currently offering at the clinical trial level, has resulted in a positive improvement in 6 out of 10 women on average. Considering the low side effect profile and cost, this result is quite successful. As one of the few centers in the world that can apply this treatment in infertility treatments, we are proud to be a pioneer.

Additional Links

Ovarian Rejuvenation with PRP